Aziyo Biologics Appoints Michelle LeRoux Williams, Ph.D as Chief Scientific Officer
August 26, 2022 09:00 ET
|
Aziyo Biologics
SILVER SPRING, Md., Aug. 26, 2022 (GLOBE NEWSWIRE) -- Aziyo Biologics, Inc. (Nasdaq: AZYO), a commercial-stage regenerative medicine company announced today that Michelle LeRoux Williams, Ph.D. has...
Aziyo Biologics to Present at the Inaugural Gilmartin Group Emerging Growth Company Showcase
August 17, 2022 16:05 ET
|
Aziyo Biologics
SILVER SPRING, Md., Aug. 17, 2022 (GLOBE NEWSWIRE) -- Aziyo Biologics, Inc. (Nasdaq: AZYO), a commercial-stage regenerative medicine company, today announced the company will present at the upcoming...
Aziyo Biologics Announces Second Quarter 2022 Financial Results and Recent Business Achievements, Including Robust Revenue Growth and Strengthened Balance Sheet
August 11, 2022 16:05 ET
|
Aziyo Biologics
SILVER SPRING, Md., Aug. 11, 2022 (GLOBE NEWSWIRE) -- Aziyo Biologics, Inc. (Nasdaq: AZYO), a commercial-stage regenerative medicine company, today provided a business update and reported financial...
Aziyo Biologics Announces $25 Million Loan Facility with SWK Holdings
August 10, 2022 18:56 ET
|
Aziyo Biologics
SILVER SPRING, Md., Aug. 10, 2022 (GLOBE NEWSWIRE) -- Aziyo Biologics, Inc. (Nasdaq: AZYO) (the “Company”), a commercial-stage regenerative medicine company announced today that it has entered into...
Aziyo Biologics Co-Founder and Regenerative Medicine Pioneer, Dr. Randy Mills, appointed Chief Executive Officer
August 09, 2022 17:58 ET
|
Aziyo Biologics
SILVER SPRING, Md., Aug. 09, 2022 (GLOBE NEWSWIRE) -- Aziyo Biologics, Inc. (Nasdaq: AZYO), a commercial-stage regenerative medicine company, today announced that Aziyo co-founder C. Randal (Randy)...
Aziyo Biologics to Report Second Quarter 2022 Financial Results on August 11, 2022
July 28, 2022 16:05 ET
|
Aziyo Biologics
SILVER SPRING, Md., July 28, 2022 (GLOBE NEWSWIRE) -- Aziyo Biologics, Inc. (Nasdaq: AZYO), a commercial-stage regenerative medicine company focused on creating the next generation of differentiated...
Aziyo Biologics Appoints Dr. C. Randal Mills as Interim President and CEO
June 21, 2022 16:05 ET
|
Aziyo Biologics
SILVER SPRING, Md., June 21, 2022 (GLOBE NEWSWIRE) -- Aziyo Biologics, Inc. (Nasdaq: AZYO), a commercial-stage regenerative medicine company focused on creating the next generation of differentiated...
Aziyo Biologics Provides Business Update and Reports First Quarter 2022 Financial Results
May 09, 2022 16:05 ET
|
Aziyo Biologics
SILVER SPRING, Md., May 09, 2022 (GLOBE NEWSWIRE) -- Aziyo Biologics, Inc. (Nasdaq: AZYO), a commercial-stage regenerative medicine company focused on creating the next generation of differentiated...
Aziyo Biologics to Report First Quarter 2022 Financial Results on Monday, May 9, 2022
April 25, 2022 16:05 ET
|
Aziyo Biologics
SILVER SPRING, Md., April 25, 2022 (GLOBE NEWSWIRE) -- Aziyo Biologics, Inc. (Nasdaq: AZYO), a commercial-stage regenerative medicine company focused on creating the next generation of...
Aziyo Biologics Announces Upcoming KOL Call Hosted by Cowen
April 12, 2022 16:05 ET
|
Aziyo Biologics
SILVER SPRING, Md., April 12, 2022 (GLOBE NEWSWIRE) -- Aziyo Biologics, Inc. (Nasdaq: AZYO), a commercial-stage regenerative medicine company focused on creating the next generation of...